PEGylation of Conjugated Linoleic Acid and its Application as an Anti-Cancer Prodrug

Article Preview

Abstract:

The objective of this study is to investigate whether the PEGylated conjugated linoleic acid (PCLA) as an anti-cancer prodrug can have favorable stability, biological activity, and prevention of proliferation in MCF-7 breast cancer cells for anti-cancer when compared with conjugated linoleic acid (CLA) itself. The CLA was simply coupled to poly(ethylene glycol) (PEG) at melting state without solvent or catalyst through ester linkage between carboxylic group of CLA and hydroxyl one of PEG. The results showed that the half life of PCLA was 55h in cell culture medium at pH 7.4 and 37°C. Apoptosis of MCF-7 breast cancer cells were induced by not only CLA- but PCLA-treatment with increasing concentrations whereas PCLA increased cell viability when compared with CLA itself. These results indicate that the PCLA is a more stable and valuable prodrug in that it has good stability and inhibition of cancer cell proliferation.

You might also be interested in these eBooks

Info:

Periodical:

Key Engineering Materials (Volumes 342-343)

Pages:

441-444

Citation:

Online since:

July 2007

Export:

Price:

Permissions CCC:

Permissions PLS:

Сopyright:

© 2007 Trans Tech Publications Ltd. All Rights Reserved

Share:

Citation:

[1] K.D. Hinds, S.W. Kim : Adv Drug Deliv Rev. Jun 17: 54(4) (2005), pp.505-530.

Google Scholar

[2] M.J. Roberts, M.D. Bentley, J.M. Harris : Adv Drug Deliv Rev. Jun 17: 54(4) (2002), pp.459-476.

Google Scholar

[3] F.M. Veronese, G. Pasut : Drug Discov. Today, Nov 1: 10(21) (2005), pp.1451-1458.

Google Scholar

[4] G. Molineux : Cancer Treat. Rev. Apr 28 Suppl A (2002), pp.13-16.

Google Scholar

[5] G.E. Francis, C. Delgado, D. Fisher, F. Malik, A.K. Agrawal : J Drug Target. 3(5) (2006), P. 321-340.

Google Scholar

[6] M. Tobio, A. Sanchez, A. Vila, I. Soriano, C. Evora, J.L. Vila-Jato, M.J. Alonso : Colloids Surf B Biointerfaces. Oct 1: 18(3-4) (2000), pp.315-323.

DOI: 10.1016/s0927-7765(99)00157-5

Google Scholar

[7] Banni S. : Curr Opin Lipidol. Jun 13(3) (2002), pp.261-266.

Google Scholar

[8] K.N. Lee, D. Kritchevsky, M.W. Pariza : Atherosclerosis. Jul 108(1) (1994), pp.19-25.

Google Scholar

[9] Y. Choi, Y. Park, J.M. Storkson, M.W. Pariza, J.M. Ntambi : Biochem Biophys Res Commun. Jun 21: 294(4) (2002), pp.785-790.

Google Scholar

[10] H. Chujo, M. Yamasaki, S. Nou, N. Koyanagi, H. Tachibana, K. Yamada : Cancer Lett. Dec 8: 202(1) (2003), pp.81-87.

Google Scholar

[11] C.D. Albright, E. Klem, A.A. Shah, P. Gallagher : Exp Mol Pathol. Oct 79(2) (2005), pp.118-125.

Google Scholar

[12] S.C. Larsson, L. Bergkvist, A. Wolk : Am J Clin Nutr. Oct 82(4) (2005), pp.894-900.

Google Scholar

[13] A. Miglietta, F. Bozzo, C. Bocca, L. Gabriel, A. Trombetta, S. Belotti, R.A. Canuto : Cancer Letter, Mar 28: 234(2) (2006), pp.149-157.

DOI: 10.1016/j.canlet.2005.03.029

Google Scholar